Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy

Scientists demonstrated that an oncogenic mutant form of NPM1 (NPM1c) impaired mitochondrial function. NPM1c also hampered formation of PML nuclear bodies, which are regulators of mitochondrial fitness and key senescence effectors.